Inventiva IVA
NASDAQ IVA
$3.56 +0.10 (+2.75%)
As of: Oct 2, 2026 · 1:23 PM EDT

Inventiva (IVA) Non Operating Interest Expenses (2020 - 2021)

Updated

Inventiva's Non Operating Interest Expenses came in at -$252.51 million for FY2025, compared with -$95.02 million in FY2024.

Analysis

Inventiva (IVA) Non Operating Interest Expenses (2020 - 2021) Analysis & Trends

Going back to FY2018, Inventiva's Non Operating Interest Expenses data covers 8 years.

  • The FY2025 figure represents the lowest annual Non Operating Interest Expenses in data going back to FY2018.
  • Per Business Quant, earlier years put Non Operating Interest Expenses at -$95.02 million in FY2024, -$7.4 million in FY2023, -$2.15 million in FY2022 and -$3.12 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 281.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -462.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -435.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 673.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 247.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Inventiva 713.04 Mn 713.04 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 -2.64 Mn
Mar 31, 2021 -2.71 Mn
Jun 30, 2020 -30,840.88
Mar 31, 2020 -14,351.21
API Access

Inventiva Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=IVA&period=max&api_key=YOUR_API_KEY